Last reviewed · How we verify

NCT04349774

Erector Spinae Plane Block vs Erector Spinae Plane Block With Serratus Anterior Plane Block in Thoracic Surgery

Withdrawn Phase 4 Last updated 14 November 2022
What this trial tests

Phase 4 trial testing Control Group - ESP block with SAP block in Pain, Postoperative. Withdrawn.

Timeline
1 October 2022
Primary endpoint
1 June 2023
30 December 2023

Quick facts

Lead sponsorAnna Uskova
PhasePhase 4
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Start date1 October 2022
Primary completion1 June 2023
Estimated completion30 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Anna Uskova — full company profile →

Who can join

Adults 18 to 90, any sex, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study will prospectively compare continuous Erector Spinae Plane block (ESP) versus combination of continuous Erector Spinae Plane block and single shot Serratus Anterior Plane block for post-operative pain management in subjects undergoing primary thoracic surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other Anna Uskova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04349774.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing